Neonatal Opioid Withdrawal Syndrome

Area of Science:

• Public Health
• Neonatal Medicine
• Substance Use Disorders

Background:

• The opioid crisis significantly affects pregnant women and infants nationwide.
• Rising rates of opioid use disorder in pregnant women and neonatal opioid withdrawal syndrome in infants are observed.
• Pregnant women often lack access to evidence-based therapies, including medication for opioid use disorder.

Purpose of the Study:

• To provide an overview of the opioid crisis's impact on the mother-infant dyad.
• To offer recommendations for managing infants with opioid exposure.
• To address the need for systematic, coordinated, and holistic care approaches.

Main Methods:

• Review of current literature and clinical practices regarding opioid use disorder in pregnancy and neonatal opioid exposure.
• Analysis of the impact on public systems like child welfare and early intervention.
• Development of evidence-based recommendations for clinical management.

Main Results:

• Pregnant women face barriers to accessing essential treatments for opioid use disorder.
• Infants exposed to opioids experience variable care, highlighting a critical gap in standardized protocols.
• Public systems are strained by the increasing number of affected children.

Conclusions:

• Systematic, enduring, coordinated, and holistic approaches are crucial for improving care for the mother-infant dyad.
• Standardized clinical guidelines for the assessment, treatment, and discharge of infants with opioid exposure are recommended.
• Addressing the opioid crisis requires a multi-faceted strategy involving healthcare providers and public systems.